scispace - formally typeset
S

Shile Huang

Researcher at LSU Health Sciences Center Shreveport

Publications -  157
Citations -  14898

Shile Huang is an academic researcher from LSU Health Sciences Center Shreveport. The author has contributed to research in topics: PI3K/AKT/mTOR pathway & P70-S6 Kinase 1. The author has an hindex of 50, co-authored 155 publications receiving 13098 citations. Previous affiliations of Shile Huang include Louisiana State University & St. Jude Children's Research Hospital.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The targets of curcumin.

Hongyu Zhou, +2 more
- 01 Mar 2011 - 
TL;DR: Various in vitro and in vivo pharmacological aspects of curcumin as well as the underlying action mechanisms are summarized, which suggest anticancer, antiviral, antiarthritic, anti-amyloid, antioxidant, and anti-inflammatory properties.
Journal ArticleDOI

Targeting mTOR signaling for cancer therapy.

Shile Huang, +1 more
- 01 Aug 2003 - 
TL;DR: Emerging results suggest that inhibition of mTOR signaling can be exploited as a potential tumour-selective therapeutic strategy.
Journal ArticleDOI

Rapamycins: mechanism of action and cellular resistance.

Shile Huang, +2 more
- 20 Mar 2003 - 
TL;DR: The conserved TOR signaling pathways, conceptual basis for tumor selectivity, and the mechanisms of resistance to this class of antitumor agent are reviewed.
Journal ArticleDOI

Host Immune Response to Influenza A Virus Infection.

Xiaoyong Chen, +6 more
- 05 Mar 2018 - 
TL;DR: How immune system, especially innate immune system and critical molecules are involved in the antiviral defense against IAVs is discussed and how IAV's antagonize different immune responses to achieve a successful infection is highlighted.